TrialPloS one2016

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.

Tania Køllgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.